Pegcetacoplan
Protein
Overview
Pegcetacoplan is a protein active pharmaceutical ingredient (ChEMBL CHEMBL4298211).
Patent & exclusivity (US)
Per the FDA Orange Book (2 approved US products), the latest listed US patent on Pegcetacoplan expires 14 Dec 2038 and exclusivity 28 Jul 2032. Generic API sourcing typically opens up once these lapse.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.